Các chiến lược theo dõi trong ung thư đầu và cổ ngoài carcinom tế bào vảy đường hô hấp trên

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108 Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon, pp 227–228 Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol 8:773–783 Gillespie MB, Albergotti WG, Eisele DW (2012) Recurrent salivary gland cancer. Curr Treat Options Oncol 13:58–70 Seifert G, Brocheriou C, Cardesa A, Eveson JW (1990) WHO international histological classification of tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract 186:555–581 Vander Poorten V, Hart A, Vauterin T et al (2009) Prognostic index for patients with parotid carcinoma: international external validation in a Belgian–German database. Cancer 115:540–550 Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134–148 NCCN clinical practice guidelines in oncology (NCCN Guidelines). 2012. www.nccn.org Terhaard CH, Lubsen H, Van der Tweel I et al (2004) Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26:681–692 (discussion 692–693) van der Putten L, de Bree R, Plukker JT et al (2006) Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck 28:902–908 Erovic BM, Schopper C, Pammer J et al (2010) Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease. Head Neck 32:1167–1172 Bell RB, Dierks EJ, Homer L, Potter BE (2005) Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 63:917–928 Burke CJ, Thomas RH, Howlett D (2011) Imaging the major salivary glands. Br J Oral Maxillofac Surg 49:261–269 Shah GV (2002) MR imaging of salivary glands. Magn Reson Imaging Clin N Am 10:631–662 Kobayashi K, Nakao K, Yoshida M et al (2009) Recurrent cancer of the parotid gland: how well does salvage surgery work for locoregional failure? ORL J Otorhinolaryngol Relat Spec 71:239–243 Pederson AW, Haraf DJ, Blair EA et al (2010) Chemoreirradiation for recurrent salivary gland malignancies. Radiother Oncol 95:308–311 Otsuka H, Graham MM, Kogame M, Nishitani H (2005) The impact of FDG-PET in the management of patients with salivary gland malignancy. Ann Nucl Med 19:691–694 Cermik TF, Mavi A, Acikgoz G, Houseni M, Dadparvar S, Alavi A (2007) FDG PET in detecting primary and recurrent malignant salivary gland tumors. Clin Nucl Med 32:286–291 Locati LD, Guzzo M, Bossi P et al (2005) Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland. Oral Oncol 41:890–894 Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD (2006) Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 116:2145–2149 Weber RS, Benjamin RS, Peters LJ, Ro JY, Achon O, Goepfert H (1986) Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 152:386–392 Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1,225 patients. Cancer 97:2530–2543 de Bree R, van der Waal I, de Bree E, Leemans CR (2010) Management of adult soft tissue sarcomas of the head and neck. Oral Oncol 46:786–790 Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS (2003) Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 57:739–747 Sobin LH, Wittekind CH (eds) (1997) UICC TNM classification of malignant tumours, ed 5. Wiley, New York, pp 101–109 Shah J, Patel S (2001) Atlas of clinical oncology-cancer of the head and neck: soft tissue and bone tumour. BC Decker Inc, Hamilton, pp 309–329 Van Damme JP, Schmitz S, Machiels JP et al (2010) Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults. Eur J Surg Oncol 36:684–690 Pellitteri PK, Ferlito A, Bradley PJ, Shaha AR, Rinaldo A (2003) Management of sarcomas of the head and neck in adults. Oral Oncol 39:2–12 Whooley BP, Mooney MM, Gibbs JF, Kraybill WG (1999) Effective follow-up strategies in soft tissue sarcoma. Semin Surg Oncol 17:83–87 Kane JM 3rd (2004) Surveillance strategies for patients following surgical resection of soft tissue sarcomas. Curr Opin Oncol 16:328–332 Whooley BP, Gibbs JF, Mooney MM, McGrath BE, Kraybill WG (2000) Primary extremity sarcoma: what is the appropriate follow-up? Ann Surg Oncol 7:9–14 Wanebo HJ, Koness RJ, MacFarlane JK et al (1992) Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 14:1–7 Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D (2010) Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out? Clin Orthop Relat Res 468:3012–3018 Kowalski LP, San CI (1994) Prognostic factors in head and neck soft tissue sarcomas: analysis of 128 cases. J Surg Oncol 56:83–88 Farhood AI, Hajdu SI, Shiu MH, Strong EW (1990) Soft tissue sarcomas of the head and neck in adults. Am J Surg 160:365–369 Arya S, Nagarkatti DG, Dudhat SB, Nadkarni KS, Joshi MS, Shinde SR (2000) Soft tissue sarcomas: ultrasonographic evaluation of local recurrences. Clin Radiol 55:193–197 Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA (1991) Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 157:353–358 Fleming JB, Cantor SB, Varma DG et al (2001) Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 92:863–868 Shuman AG, Light E, Olsen SH et al (2011) Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg 137:331–337 Patel SG, Prasad ML, Escrig M et al (2002) Primary mucosal malignant melanoma of the head and neck. Head Neck 24:247–257 Yanagi T, Mizoe JE, Hasegawa A et al (2009) Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 74:15–20 Gavriel H, McArthur G, Sizeland A, Henderson M (2011) Review: mucosal melanoma of the head and neck. Melanoma Res 21:257–266 Goldsmith HS (1979) Melanoma: an overview. CA Cancer J Clin 29:194–215 Lee CC, Faries MB, Wanek LA, Morton DL (2009) Improved survival for stage IV melanoma from an unknown primary site. J Clin Oncol 27:3489–3495 Lentsch EJ, Myers JN (2001) Melanoma of the head and neck: current concepts in diagnosis and management. Laryngoscope 111:1209–1222 Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB (2010) Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol 28:3042–3047 Livingstone E, Windemuth-Kieselbach C, Eigentler TK et al (2011) A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer 47:1977–1989 Bafounta ML, Beauchet A, Chagnon S, Saiag P (2004) Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol 5:673–680 Balch CM, Gershenwald JE, Soong SJ et al (2010) Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 28:2452–2459 Curti BD, Urba WJ (2012) Integrating new therapies in the treatment of advanced melanoma. Curr Treat Options Oncol 13:327–339 Flaherty KT, Robert C, Hersey P et al (2012) Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 367:107–114 Robert C, Thomas L, Bondarenko I et al (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364:2517–2526 Digonnet A, Hamoir M, Andry G et al (2012) Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol [Epub ahead of print] Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26:1–26 Vauterin TJ, Veness MJ, Morgan GJ, Poulsen MG, O’Brien CJ (2006) Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck 28:785–791 Kyrgidis A, Tzellos TG, Kechagias N et al (2010) Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer 46:1563–1572 Palme CE, MacKay SG, Kalnins I, Morgan GJ, Veness MJ (2007) The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 15:103–106 Ch’ng S, Clark JR, Brunner M, Palme CE, Morgan GJ, Veness MJ (2012) Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head Neck [Epub ahead of print] Ebrahimi A, Moncrieff MD, Clark JR et al (2010) Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck 32:1288–1294 Kelder W, Ebrahimi A, Forest VI, Gao K, Murali R, Clark JR (2012) Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread. Ann Surg Oncol 19:274–279 Maubec E, Petrow P, Scheer-Senyarich I et al (2011) Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 29:3419–3426 Chen J, Ruczinski I, Jorgensen TJ et al (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100:1215–1222 Franchi A, Santucci M, Wenig BM (2005) Adenocarcinoma. Tumours of the nasal cavity and paranasal sinuses. In: Barnes L, Eveson JW, Reichardt P, Sidransky D (eds) World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon, pp 20–23 Leivo I (2007) Update on sinonasal adenocarcinoma: classification and advances in immunophenotype and molecular genetic make-up. Head Neck Pathol 1:38–43 Lund VJ, Chisholm EJ, Takes RP et al (2012) Evidence for treatment strategies in sinonasal adenocarcinoma. Head Neck 34:1168–1178 Choussy O, Ferron C, Védrine PO et al (2008) Adenocarcinoma of ethmoid: a GETTEC retrospective multicenter study of 418 cases. Laryngoscope 118:437–443 Allen MW, Schwartz DL, Rana V et al (2008) Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys 71:401–406 Van Gerven L, Jorissen M, Nuyts S, Hermans R, Vander Poorten V (2011) Long-term follow-up of 44 patients with adenocarcinoma of the nasal cavity and sinuses primarily treated with endoscopic resection followed by radiotherapy. Head Neck 33:898–904 Lund VJ, Stammberger H, Nicolai P et al (2010) European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 1:1–143 Acheson ED, Hadfield EH, Macbeth RG (1967) Carcinoma of the nasal cavity and accessory sinuses in woodworkers. Lancet 1:311–312 Sasaki M, Eida S, Sumi M, Nakamura T (2011) Apparent diffusion coefficient mapping for sinonasal diseases: differentiation of benign and malignant lesions. AJNR Am J Neuroradiol 32:1100–1106